Excell Partners is a venture capital firm founded in 2005 and located in Rochester, New York. It specializes in seed and early-stage investments across various sectors, including medical devices, biotechnology, energy, ag-tech, imaging, information technology, and software. While Excell operates as a not-for-profit organization supported by New York State, it employs a for-profit discipline by utilizing convertible debt and equity structures in its investments. This approach aims to ensure that the firm becomes self-sustaining over time, allowing it to continue its mission of supporting innovative startups.
Thread specializes in enterprise-scale autonomous data collection that delivers precise inspection insights. Its suite of tools empowers users to programmatically capture knowledge into consistent and replicable plans. Any visual inspection activity being performed by a pilot in GPS-accessible locations today can be automated through Airtonomy. These tools can be used to make full end-to-end automated workflows as they have done with its wind product.
NeuroGenesis
Series A in 2022
NeuroGenesis is a biotechnology company that focuses on developing cell therapies for neurodegenerative diseases. Its primary innovation is the NG CELL™ technology, which uses the patient’s own stem cells to deliver remyelinating and regenerative proteins. This process begins with the collection of bone marrow from the patient, allowing for the neutralization of the stem cell protocol. By maximizing the potential for immunomodulation, neuronal protection, and regeneration, NeuroGenesis aims to enable healthcare professionals to utilize these cells to deliver therapeutic effects directly to affected areas in the brain. The company's approach represents a significant advancement in the treatment of conditions that impact neural health.
OWL Autonomous Imaging
Series A in 2022
Owl Autonomous Imaging delivers Monocular 3D Thermal Ranging™ solutions to industrial and automotive mobility markets to dramatically enhance safety day or night and in all weather conditions. Thermal Ranging™ is a new 3D modality that uses optical fusion and novel deep learning techniques to extract dense range maps from radiated heat signatures, without requiring illumination. Owl was co-founded by Chuck Gershman. Mr. Gershman has 30 years of semiconductor industry experience in executive management, marketing, engineering, business development, sales, consulting and executive advising. A serial entrepreneur, Mr. Gershman has been a member of the executive team of five startups, three of which as CEO/COO. He has had successful exits with acquisitions by Intel and PMC-Sierra. Further company information can be found at www.owlai.us
SunDensity
Venture Round in 2021
SunDensity has developed a groundbreaking Photonic Smart Coating (PSC™) technology that enables the up and down conversion of the wavelengths in white light (UV to IR) to match the desired band which can solve several in-efficiencies in photonics. By conversion of spectrum, they have developed, and field tested a patent-pending PSC™ that significantly reduces the cost of electricity generated by solar photovoltaics (PV) applications, customizes thermal and optical behavior of architectural glass, and increases the quantum efficiency of optoelectronic instruments.
Conamix
Venture Round in 2021
Conamix is focused on developing innovative, low-cost high-energy materials specifically for the lithium-ion battery market. Founded in 2014, the company specializes in nano-structured silicon advanced battery materials that enhance energy density while reducing costs. These materials are designed to seamlessly integrate with existing manufacturing processes, allowing manufacturers to improve the performance of their lithium-ion systems. Conamix benefits from intellectual property agreements with leading global research institutions, positioning itself as a key player in the evolution of rechargeable battery technology. The company's commitment to creating cobalt-free battery materials aims to yield greater energy outputs compared to current options, thereby addressing the growing demand for more efficient energy storage solutions.
RealEats
Series A in 2021
RealEats is a food tech company specializing in premium meal prep delivery services. The company offers a range of healthy, chef-designed meals that prioritize nutritional value and sustainability. RealEats meals are prepared using whole, unprocessed ingredients sourced responsibly, with many components coming from local farms in the Finger Lakes region of New York. By providing meals in single portion sizes and vacuum-packed for freshness, RealEats aims to simplify the process of enjoying nutritious food while also reducing food waste. This approach enables consumers to access convenient, handmade meals without compromising on quality or health.
Karma Wellness Water
Seed Round in 2020
Karma Wellness Water is a manufacturer of naturally enhanced flavored spring water, designed to provide a nutritious beverage option. The company offers water that contains high levels of vitamins and nutrients, delivered in a mix-to-drink format through its innovative push cap bottles. This packaging allows consumers to access a proprietary blend of probiotics, vitamins, and antioxidants at their optimal potency, promoting both health and convenience.
Casana
Seed Round in 2020
Casana is a healthcare technology company based in Rochester, New York, that specializes in in-home cardiac health monitoring solutions. Its flagship product, the Heart Seat, is a cloud-connected toilet seat designed to allow patients to effortlessly monitor critical health metrics such as heart rate, blood pressure, blood oxygenation, and cardiac output from the comfort of their homes. The Heart Seat integrates three key sensors: a single-lead ECG for measuring the heart's electrical activity, PPG sensors that assess blood volume, and BCG sensors that track the mechanical activity of the heart. This innovative device aims to assist medical teams in managing chronic conditions by providing continuous, reliable health data outside traditional healthcare settings. Casana's technology is focused on fostering proactive health management and improving patient outcomes.
WexEnergy
Pre Seed Round in 2020
WexEnergy LLC, founded in 2018 and based in Rochester, New York, specializes in innovative plastics manufacturing with a focus on enhancing energy efficiency in buildings. The company has developed a transparent window insulation technology that transforms single-pane windows to perform like double-pane windows, thereby significantly improving thermal insulation. This patented insulation system is designed to be mounted on existing windows, optimizing energy efficiency without the need for complete replacements. By providing an affordable solution that reduces energy bills, WexEnergy enables building owners to enhance comfort, improve cash flow, and ultimately increase property values and profitability.
VPG Medical
Seed Round in 2020
VPG Medical is a digital health service company developing a unique set of monitoring solutions based on groundbreaking research using video-based sensors embedded in smart devices and personal computers.The company is dedicated to providing effortless monitoring solutions to improve the lives of patients requiring continuous monitoring of their health status.
Adarza BioSystems
Series D in 2020
Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, founded in 2008. The company specializes in developing a rapid and label-free biological assay platform that measures clinical and point-of-care samples. This innovative platform employs diagnostic arrayed imaging reflectometry (AIR) to enable the simultaneous detection of hundreds of analytes from a single drop of fluid, allowing healthcare professionals to conduct sophisticated tests with high sensitivity and specificity. By significantly reducing the time required for testing, Adarza BioSystems aims to enhance diagnostic capabilities in various healthcare settings.
Soos
Venture Round in 2020
Soos specializes in developing an innovative incubation system that influences the sex development process in poultry embryos. By utilizing AI-driven software and customized incubation cells, the company controls and monitors environmental conditions during incubation. This system also employs sound wave technology to transform genetic male chicks into functional female layers capable of egg production. Soos's approach aims to enhance the productivity of the egg production industry, contributing to global nutritional security by maximizing the output of female layers.
EkoStinger
Venture Round in 2019
EkoStinger specializes in advanced aerodynamic solutions for the trucking industry, focusing on enhancing fuel efficiency through innovative trailer devices. The company's flagship product, the Sliding Stinger, is designed to actively adjust with the tandems, ensuring optimal performance in various driving conditions. This technology not only enhances fuel efficiency but also protects airlines and suspension systems while effectively managing crosswinds. EkoStinger aims to offer a reliable alternative to traditional side skirts, addressing the challenges faced by fleet professionals who seek to improve their operational efficiency.
Rialto Markets
Seed Round in 2019
Rialto Markets operates a digital trading and investing platform focused on the fixed income market, providing innovative tools that facilitate capital formation for issuers, investors, and traders. The company has created three distinct products that enhance liquidity sourcing, which can be utilized independently or in combination for greater effectiveness. Their platform integrates pre-trade analytics, anonymous crossing, and advanced data mining capabilities, allowing users to discreetly execute large block trades while minimizing market impact. Through these offerings, Rialto Markets aims to streamline and improve the trading experience for participants in the fixed income sector.
Kinvolved
Seed Round in 2018
Kinvolved, Inc. is a technology company that specializes in mobile and web applications aimed at enhancing communication between schools and families. Its flagship product, KiNVO, facilitates communication regarding attendance, behavior, grades, and other important updates, allowing schools to send messages to entire classrooms or individual parents. The platform also provides valuable data analytics, enabling educators to track attendance and communication trends, flag chronically absent students, and generate reports on student-specific interactions with parents. Kinvolved's solutions target schools and after-school programs, particularly in underserved communities across the United States, with the goal of improving student attendance and reducing chronic absenteeism. Founded in 2012 and based in New York City, Kinvolved combines technology with community engagement to foster better educational outcomes and enhance graduation rates.
Splyce
Venture Round in 2018
Splyce is working to build the new eSports experience. We are the 'TV Guide' for eSports, host a major editorial hub where many of the top names in eSports write about the state of the industry, and have a top tier Pro Team in CSGO, Hearthstone, Smash Bros Melee,World of Warcraft, Call of Duty, Overwatch, and the European LCS. Our website is splyce.gg
Glauconix Biosciences
Seed Round in 2018
Glauconix Biosciences, Inc. is a biotechnology company focused on advancing ophthalmic drug development through its innovative platform technology. Founded in 2014 and based in Albany, New York, the company specializes in drug screening and discovery, dose response assessment, and safety and toxicity evaluations. Glauconix develops ex-vivo dynamic three-dimensional human tissue models that closely mimic human physiology and genetics, enabling efficient testing of compounds across diverse population genetics. Its services also include identifying potential drug targets and validating effective compounds, thereby reducing the overall cost and time involved in ophthalmic drug development.
WexEnergy
Seed Round in 2018
WexEnergy LLC, founded in 2018 and based in Rochester, New York, specializes in innovative plastics manufacturing with a focus on enhancing energy efficiency in buildings. The company has developed a transparent window insulation technology that transforms single-pane windows to perform like double-pane windows, thereby significantly improving thermal insulation. This patented insulation system is designed to be mounted on existing windows, optimizing energy efficiency without the need for complete replacements. By providing an affordable solution that reduces energy bills, WexEnergy enables building owners to enhance comfort, improve cash flow, and ultimately increase property values and profitability.
EkoStinger
Seed Round in 2018
EkoStinger specializes in advanced aerodynamic solutions for the trucking industry, focusing on enhancing fuel efficiency through innovative trailer devices. The company's flagship product, the Sliding Stinger, is designed to actively adjust with the tandems, ensuring optimal performance in various driving conditions. This technology not only enhances fuel efficiency but also protects airlines and suspension systems while effectively managing crosswinds. EkoStinger aims to offer a reliable alternative to traditional side skirts, addressing the challenges faced by fleet professionals who seek to improve their operational efficiency.
GRYT Health
Seed Round in 2018
GRYT Health is a digital health company focused on improving health outcomes for individuals dealing with cancer and other chronic illnesses. Utilizing proprietary direct-to-patient technology, GRYT Health offers valuable patient data, research analytics, and marketing services tailored for pharmaceutical companies throughout the drug development and commercialization process. The company also supports clinical trial recruitment and patient education, empowering patients to take charge of their health. GRYT Health has established itself as a preferred partner for many leading pharmaceutical companies, biotech firms, and clinical research organizations due to its unique market position and access to critical patient insights.
CypherWorx
Venture Round in 2017
CypherWorX is an e-learning solutions company that partners with small businesses and non-profit corporations. It partners with business-to-business, association, and CRM clients by providing holistic e-Learning solutions. It was founded in 2009 and headquartered in Rochester, New York.
TenCar
Seed Round in 2017
Tencar, Inc. is a company that specializes in developing ostomy appliances for colostomy and ileostomy patients, focusing on those with active lifestyles. Its flagship product, The Choice Cap System, features a double-flanged attachment method that includes a lightweight, airtight, and molded waterproof cap. This cap can be used with or without a traditional soft inner pouch, providing an added layer of protection against leakage and odors. The system consists of three components: The Choice Cap, a plastic prosthetic device for waste management; the Dual-Flanged Choice Cap Wafer, which serves multiple functions; and a pouch that attaches to the wafer's inner flange for enhanced security. Founded in 2011 and based in Batavia, New York, Tencar aims to improve the quality of life for the nearly one million ostomy patients in the United States by enhancing their confidence and body image through its innovative products.
Sanabit Technologies
Seed Round in 2017
Sanabit Technologies specializes in non-invasive medical technology aimed at accelerating wound and bone healing. The company develops products that utilize low-intensity magnetic fields to stimulate the body's natural repair processes, enhancing the efficiency of mitochondria. This innovative approach results in quicker recovery times and healthier tissue, offering a pain-free and non-intrusive alternative for patients. The technology is designed to be cost-effective while promoting enhanced healing, making it a valuable addition to healthcare solutions focused on improving patient outcomes.
Diligence lab
Seed Round in 2017
Diligence Lab specializes in developing cost-effective genetic diagnostic test kits and human genetic screening solutions. In addition to its focus on genetic diagnostics, the company has created a talent management platform that aims to eliminate unconscious bias in hiring. This platform leverages artificial intelligence and machine learning to analyze data from various sources, including global databases and social media. It assists students in identifying job opportunities that align with their skills and profiles, while also enabling employers to discover pre-assessed candidates who match their organizational culture. Through these offerings, Diligence Lab addresses both healthcare and employment challenges, promoting better outcomes in genetic testing and talent acquisition.
SelfArray
Seed Round in 2017
SelfArray is a company based in Troy, New York, founded in 2015, that specializes in directed self-assembly technology for LED displays. Its innovative approach leverages diamagnetic levitation to efficiently and cost-effectively assemble chip-on-board (CoB) LEDs into pixel arrays. This method allows for the rapid combination of millions of LEDs, facilitating their transfer to printed circuit boards (PCBs) for bonding in a parallel manner. By streamlining the assembly process, SelfArray helps direct-view LED display manufacturers reduce costs while adapting to the industry's shift towards more economical and unpackaged LED solutions.
Viggi Kids
Venture Round in 2017
Viggi Kids, Corp. specializes in designing and manufacturing innovative seating solutions for children. One of its flagship products is the Vidget chair, a versatile three-in-one design that easily transforms from a chair to a desk or stool. The chairs are engineered to provide a flexible seating system that allows for side-to-side and front-to-back rocking motion, which helps children release energy and enhances focus and attention, particularly in educational settings. Viggi Kids also offers the Digit Widgit, a learning tool aimed at facilitating early numeracy skills. Their products are utilized in various environments, including classrooms, therapy centers, and libraries, and are available for purchase online. Founded in 2015, the company is headquartered in Fairport, New York.
Conamix
Seed Round in 2016
Conamix is focused on developing innovative, low-cost high-energy materials specifically for the lithium-ion battery market. Founded in 2014, the company specializes in nano-structured silicon advanced battery materials that enhance energy density while reducing costs. These materials are designed to seamlessly integrate with existing manufacturing processes, allowing manufacturers to improve the performance of their lithium-ion systems. Conamix benefits from intellectual property agreements with leading global research institutions, positioning itself as a key player in the evolution of rechargeable battery technology. The company's commitment to creating cobalt-free battery materials aims to yield greater energy outputs compared to current options, thereby addressing the growing demand for more efficient energy storage solutions.
Traverse Biosciences
Seed Round in 2016
Traverse Biosciences is a privately-held bioscience company established in June 2013 to commercialize a proprietary library of new molecular entities invented at Stony Brook University. Our lead candidate, TRB-N0224, is envisioned as the first FDA-approved, once-daily prescription medication for the prevention and control of canine periodontal disease. We are also pursuing complimentary therapeutic indications for TRB-N0224, as well as additional drug candidates in the pipeline with implications for both human and veterinary medicine. Traverse Biosciences was named to reflect our core mission to successfully navigate the "valley of death" separating early-stage academic technologies from becoming viable commercial products for the benefit of health, society and the economy. Our business model is centered around the achievement of key technical milestones in alignment with a validated market opportunity and a clear exit strategy. With the support of our investors and stakeholders, our goal is to strategically mitigate product development risks and add tangible commercial value to our assets.
Sensor Films
Venture Round in 2016
Sensor Films Inc. specializes in advancing digital manufacturing processes with a focus on the electronic products sector. The company has developed the Starlight Digital Manufacturing Platform, which utilizes ink jet deposition technology to facilitate rapid and cost-effective prototyping as well as high-volume production. This platform serves the specialty graphics and printable electronics industries, offering streamlined workflows that enhance efficiency. Sensor Films' systems are designed to print both functional and decorative inks on various substrates, including flexible and rigid materials, making them suitable for a diverse range of consumer and industrial applications. By integrating pre- and post-printing processes, the company enables clients to accelerate product development, reduce time to market, and undertake economical short run production, thereby transforming traditional manufacturing methodologies.
Construction Robotics
Venture Round in 2016
Construction Robotics is focused on advancing construction through the use of new technology and the same manufacturing principles used for decades in other industries. By leveraging new technology CR believes there can be significant improvements to the way the construction industry operates.
GiveGab
Seed Round in 2015
GiveGab provides services for fundraising professionals to raise money online. Designed for cause-based organizations, community foundations, and education institutions, GiveGab offers a complete suite of products and services. The company was founded in 2011 and headquartered in Ithaca, New York.
Pharmapotheca A
Seed Round in 2015
Technology Development and Consulting Services to the Pharmaceutical, Veterinary, Cosmetic, Agrochemical, Nutritional, and Flavor and Fragrance industries .
Molecular Glasses
Seed Round in 2015
Molecular Glasses, Inc. specializes in the development of non-crystallized molecular glasses aimed at enhancing the performance and longevity of organic light-emitting diodes (OLEDs) and other organic electronic devices. Founded in 2015 and based in Rochester, New York, the company provides a range of proprietary materials for OLED manufacturers, particularly in automotive electronics and lighting applications. Its product portfolio includes hole-transporting, electron-transporting, ambipolar, fluorescent, phosphorescent, and cross-linkable materials that are soluble in water, alcohol, and green solvents. By offering amorphous and soluble small molecules that prevent the aggregation of dopant emitters, Molecular Glasses helps clients achieve significant improvements in OLED lifespan and reliability, thereby facilitating broader adoption of OLED technology.
Efferent Labs
Seed Round in 2014
Efferent Labs, Inc. is a preclinical stage biotechnology company specializing in implantable biosensors for life sciences. The company’s flagship product, the CytoComm Biosensor Platform, utilizes engineered living cell lines to monitor biological signaling and cellular responses in real time. This innovative system allows researchers to collect multiple data points from the same subject over the course of a study, enabling tailored treatments in clinical settings, particularly in oncology, cardiology, and metabolic diseases. The data collected is transmitted through the cloud to a dedicated software platform, providing researchers and clinicians with immediate insights. Founded in 2011 and headquartered in Buffalo, New York, Efferent Labs operates as a subsidiary of Raland Compliance Partners, LLC, having rebranded from Raland Therapeutics, Inc. in 2015.
First Wave Technologies
Venture Round in 2014
First Wave Technologies, Inc. is a venture capital firm located in Batavia, New York, that focuses on investing in start-ups within the medical devices, pharmaceuticals, diagnostics, and consumer markets. The firm distinguishes itself by providing a complete management team to its portfolio companies, which allows for a collaborative approach to accelerate the advancement of technologies from research to market. Additionally, First Wave manufactures medical devices designed to enhance the ease and accuracy of pharmaceutical delivery, improving the overall healthcare experience. By leveraging clinical insights and engineering expertise, the company aims to establish new standards of care that benefit both patients and caregivers.
Augmate
Seed Round in 2014
Augmate offers an IoT and wearable device management platform that allows organizations to develop end-point solutions, bringing the power of IoT, blockchain, and AI to the world. The company's goal is to connect all things with the same powerful simplicity of wearables. The company's blockchain-based protocol-agnostic platform provides growth that enables enterprises to manage IoT devices. It aggregates sensor data through a secure network of wearable devices and beacons. To optimize conditions for safe and productive actions, it manages the distribution of information across a workforce. The company's current hardware partners are Google Glass, Vuzix, Epson, Uvex, Recon Instruments, and Optinvent. Augmate was founded in 2013 and is based in New York.
Yorango
Seed Round in 2014
Yorango is focused on creating a comprehensive real estate platform that simplifies the rental process. The company develops property-management software that aids clients in collaborating with landlords to secure optimal locations and rates for leases and sub-rentals. In addition to this, Yorango offers various real estate consultancy services, including general practice surveying, fund management, destination consulting, and property co-investment. These services are designed to help clients find the right properties at competitive prices, enhancing their overall rental experience.
MICROrganic Technologies
Seed Round in 2013
MICROrganic Technologies is a biotech company focused on successfully scaling and bringing-to-market MFC offerings for wastewater treatment applications. Cleaning the world's ever-increasing wastewater output will be revolutionized by MICROrganic's platform MFC technology, which aims to dramatically reduce energy usage while generating electricity and efficiently treating wastewater. MICROrganic Technologies manufactures high-efficiency secondary wastewater treatment systems - an alternative that reduces energy costs 80%+ and provides real-time process intel. It was established in 2010 and is based in Castleton On Hudson, New York, United States.
StrongArm Tech
Seed Round in 2013
StrongArm Tech provides SaaS solutions to Fortune 2000 companies that prevent workplace injuries. .
GiveGab
Seed Round in 2013
GiveGab provides services for fundraising professionals to raise money online. Designed for cause-based organizations, community foundations, and education institutions, GiveGab offers a complete suite of products and services. The company was founded in 2011 and headquartered in Ithaca, New York.
VitaScan
Seed Round in 2013
VitaScan is a medical device manufacturing company focused on developing portable finger-stick tests for detecting vitamin and micronutrient deficiencies. With an initial emphasis on iron deficiency, which affects approximately one-third of the global population, VitaScan addresses a significant gap in standard healthcare practices where such deficiencies are often overlooked. The company's innovative system provides direct measurements of vitamin levels, allowing individuals to monitor their nutritional status and make informed dietary adjustments. This user-friendly approach enables people to test and track their micronutrient levels conveniently from the comfort of their homes.
GiveGab
Seed Round in 2013
GiveGab provides services for fundraising professionals to raise money online. Designed for cause-based organizations, community foundations, and education institutions, GiveGab offers a complete suite of products and services. The company was founded in 2011 and headquartered in Ithaca, New York.
Yorango
Seed Round in 2012
Yorango is focused on creating a comprehensive real estate platform that simplifies the rental process. The company develops property-management software that aids clients in collaborating with landlords to secure optimal locations and rates for leases and sub-rentals. In addition to this, Yorango offers various real estate consultancy services, including general practice surveying, fund management, destination consulting, and property co-investment. These services are designed to help clients find the right properties at competitive prices, enhancing their overall rental experience.
Graphenix Development
Seed Round in 2012
Graphenix Development.(“GDI”), founded in 2009, is a leader in graphenic dispersions, coatings, and high value applications. GDI's core competitive advantage is product oriented chemistry. GDI produces "Graphenic Intermediate Dispersion Systems" under their product line GRIDS(TM). GDI has developed a conductive ink with IIMAK, that was launched globally in Q1 2013. GDi will continue to develop new products with current and new partners.
Pharmadva
Seed Round in 2011
PharmAdva develops a product that delivers improved quality of life for patients.
e2e Materials
Series A in 2010
e2e Materials, Inc. develops, designs, engineers and produces proprietary biocomposites, providing a totally new, unparalleled environmental solution that is transforming the $27B industrial (OEM) wood products marketplace. The product is unique in that its performance so vastly outperforms industry legacy products, that its remarkable green attributes actually take second billing. e2e’s venture-backed team comprised of experienced market, technology development and manufacturing leadership is forging the new model for greentech/cleantech start-ups: * One that exceeds the requirements of pending, significant industry legislation * Offers a new tier of performance, design capability and safety * Enables OEM customers to vastly reduce operational cost and increase efficiency * Repositions struggling, domestic manufacturers to outpace foreign competition * Creates green-collar jobs spanning agriculture, manufacturing and high tech fields * Unparalleled sustainability story using no petroleum or formaldehyde, but is made from soy flour and grass fibers, is biodegradable, fire retardant and multiples stronger than wood composites * Leverages a regional business model that scales globally
AndroBioSys
Venture Round in 2009
AndroBioSys, Inc. (ABS), is a biotechnology company dedicated to the development of novel treatments for prostate disease. Based on technologies developed at Roswell Park Cancer Institute, AndroBioSys is pioneering new approaches to make treatment of prostate cancer curative, not palliative. Preventing progression of prostate disease is intertwined intimately with disruption of the androgen axis. ABS performs contract research screening services for academic, biotechnology and pharmaceutical clients and develops collaborative partnerships to discover new drugs to proprietary prostate disease targets.
Koning
Seed Round in 2007
Koning’s vision is to create a revolution in medical imaging through our advanced Computed Tomography technology. Koning’s 3D KBCT produces high-contrast Real 3D images of the breast with exceptional spatial resolution, no painful compression, in a rapid 10-second exposure, at radiation levels in the range of diagnostic mammograms. We believe our 3D Koning Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. Future versions of our technology are expected to optimize early disease detection, diagnosis, intervention and treatment in numerous areas of the body. Our hope is to be able to improve survival rates and outcomes for millions of patients. We believe that the power, versatility and lower cost of Koning Breast CT will serve as a viable substitute for many traditional imaging applications.
Cerion Technology
Series A in 2007
Cerion Technology produces diesel and power products.
TetraGenetics
Seed Round in 2007
TetraGenetics, Inc. is a biotechnology company focused on developing therapeutic proteins and vaccines for the biopharmaceutical industry. Established in 2004 and based in Arlington, Massachusetts, the company utilizes its proprietary TetraExpress system to produce recombinant human ion channel proteins and other complex biologics. TetraGenetics specializes in the production of eukaryotic membrane and secretory proteins, which are often difficult to express using conventional systems. Among its products is IchVax, a recombinant subunit vaccine aimed at preventing white-spot disease in freshwater fish. The company is also engaged in a strategic research and development collaboration with Imbrium Therapeutics L.P., aiming to address autoimmune diseases and provide solutions for ion channel-related conditions. TetraGenetics' technology enables rapid production of properly folded, functional transmembrane proteins, positioning the company as a valuable player in the development of novel therapeutics and vaccines for both human and animal health.
TetraGenetics
Seed Round in 2005
TetraGenetics, Inc. is a biotechnology company focused on developing therapeutic proteins and vaccines for the biopharmaceutical industry. Established in 2004 and based in Arlington, Massachusetts, the company utilizes its proprietary TetraExpress system to produce recombinant human ion channel proteins and other complex biologics. TetraGenetics specializes in the production of eukaryotic membrane and secretory proteins, which are often difficult to express using conventional systems. Among its products is IchVax, a recombinant subunit vaccine aimed at preventing white-spot disease in freshwater fish. The company is also engaged in a strategic research and development collaboration with Imbrium Therapeutics L.P., aiming to address autoimmune diseases and provide solutions for ion channel-related conditions. TetraGenetics' technology enables rapid production of properly folded, functional transmembrane proteins, positioning the company as a valuable player in the development of novel therapeutics and vaccines for both human and animal health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.